{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:10:54Z","timestamp":1790169054538,"version":"4.1.0"},"reference-count":53,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T-cell responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been described in recovered patients, and may be important for immunity following infection and vaccination as well as for the development of an adoptive immunotherapy for the treatment of immunocompromised individuals. In this report, we demonstrate that SARS-CoV-2\u2013specific T cells can be expanded from convalescent donors and recognize immunodominant viral epitopes in conserved regions of membrane, spike, and nucleocapsid. Following in vitro expansion using a good manufacturing practice-compliant methodology (designed to allow the rapid translation of this novel SARS-CoV-2 T-cell therapy to the clinic), membrane, spike, and nucleocapsid peptides elicited interferon-\u03b3 production, in 27 (59%), 12 (26%), and 10 (22%) convalescent donors (respectively), as well as in 2 of 15 unexposed controls. We identified multiple polyfunctional CD4-restricted T-cell epitopes within a highly conserved region of membrane protein, which induced polyfunctional T-cell responses, which may be critical for the development of effective vaccine and T-cell therapies. Hence, our study shows that SARS-CoV-2 directed T-cell immunotherapy targeting structural proteins, most importantly membrane protein, should be feasible for the prevention or early treatment of SARS-CoV-2 infection in immunocompromised patients with blood disorders or after bone marrow transplantation to achieve antiviral control while mitigating uncontrolled inflammation.<\/jats:p>","DOI":"10.1182\/blood.2020008488","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T13:07:21Z","timestamp":1603717641000},"page":"2905-2917","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":127,"title":["SARS-CoV-2\u2013specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8323-3085","authenticated-orcid":false,"given":"Michael D.","family":"Keller","sequence":"first","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"Division of Allergy and Immunology, Children\u2019s National Hospital, Washington, DC;"},{"name":"GW Cancer Center, George Washington University, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Harris","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariah A.","family":"Jensen-Wachspress","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaishnavi V.","family":"Kankate","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haili","family":"Lang","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Lazarski","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Durkee-Shock","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6491-2410","authenticated-orcid":false,"given":"Ping-Hsien","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajal","family":"Chaudhry","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Webber","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anushree","family":"Datar","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Terpilowski","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily K.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3951-6496","authenticated-orcid":false,"given":"Eva M.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Val","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Shancer","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ulrey","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5538-2649","authenticated-orcid":false,"given":"Uduak","family":"Ekanem","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Stanojevic","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Geiger","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8772-5984","authenticated-orcid":false,"given":"Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Statistics, George Washington University, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmida","family":"Hoq","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2019-0887","authenticated-orcid":false,"given":"Allistair A.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"GW Cancer Center, George Washington University, Washington, DC;"},{"name":"Division of Blood and Marrow Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0102-7892","authenticated-orcid":false,"given":"Patrick J.","family":"Hanley","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"GW Cancer Center, George Washington University, Washington, DC;"},{"name":"Division of Blood and Marrow Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7065-3769","authenticated-orcid":false,"given":"C. Russell","family":"Cruz","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"GW Cancer Center, George Washington University, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children\u2019s National Hospital, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesia","family":"Dropulic","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Gangler","sequence":"additional","affiliation":[{"name":"Leidos Biomedical Research, Inc, Frederick National Laboratory, Frederick, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter D.","family":"Burbelo","sequence":"additional","affiliation":[{"name":"National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-1231","authenticated-orcid":false,"given":"R. Brad","family":"Jones","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Weill Cornell Medicine, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5140-9090","authenticated-orcid":false,"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[{"name":"Center for Cancer and Immunology Research and"},{"name":"GW Cancer Center, George Washington University, Washington, DC;"},{"name":"Division of Blood and Marrow Transplantation and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2020121716301540700_B1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"2020121716301540700_B2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"2020121716301540700_B3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/infdis\/jiaa273","article-title":"Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to Spike protein in COVID-19 patients","volume":"222","author":"Burbelo","year":"2020","journal-title":"J Infect Dis"},{"issue":"7","key":"2020121716301540700_B4","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"key":"2020121716301540700_B5","first-page":"1","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"2020","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"2020121716301540700_B6","article-title":"The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity [published online ahead of print 21 May 2020]","author":"Thieme","journal-title":"medRxiv"},{"issue":"48","key":"2020121716301540700_B7","doi-asserted-by":"crossref","first-page":"eabd2071","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"issue":"1","key":"2020121716301540700_B8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"issue":"11","key":"2020121716301540700_B9","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41590-020-0782-6","article-title":"Broad and strong memory CD4 (+) and CD8 (+) T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients","volume":"21","author":"Peng","year":"2020","journal-title":"Nat Immunol"},{"key":"2020121716301540700_B10","article-title":"Intrafamilial exposure to SARS-CoV-2 induces cellular immune response without seroconversion [published online ahead of print 22 June 2020]","author":"Gallais","journal-title":"medRxiv"},{"key":"2020121716301540700_B11","article-title":"Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19 [published online ahead of print]","author":"Oja","journal-title":"Eur J Immunol"},{"issue":"6","key":"2020121716301540700_B12","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1158\/2159-8290.CD-20-0422","article-title":"Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak","volume":"10","author":"Dai","year":"2020","journal-title":"Cancer Discov"},{"issue":"3","key":"2020121716301540700_B13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"2","key":"2020121716301540700_B14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2006.05.002","article-title":"Long-lived effector\/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients","volume":"120","author":"Yang","year":"2006","journal-title":"Clin Immunol"},{"issue":"8","key":"2020121716301540700_B15","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"issue":"22","key":"2020121716301540700_B16","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1182\/blood-2010-06-289991","article-title":"Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects","volume":"116","author":"Melenhorst","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2020121716301540700_B17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3109\/14653241003709686","article-title":"Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience","volume":"12","author":"Cruz","year":"2010","journal-title":"Cytotherapy"},{"issue":"18","key":"2020121716301540700_B18","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"issue":"242","key":"2020121716301540700_B19","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"31","key":"2020121716301540700_B20","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem-cell transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J Clin Oncol"},{"issue":"17","key":"2020121716301540700_B21","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1182\/bloodadvances.2019000371","article-title":"\u201cMini\u201d bank of only 8 donors supplies CMV-directed T cells to diverse recipients","volume":"3","author":"Tzannou","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"2020121716301540700_B22","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"issue":"11","key":"2020121716301540700_B23","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2020121716301540700_B24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1172\/JCI121127","article-title":"Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation","volume":"130","author":"Prockop","year":"2020","journal-title":"J Clin Invest"},{"issue":"9","key":"2020121716301540700_B25","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/bmt.2016.17","article-title":"Virus-specific T-cell banks for \u201coff the shelf\u201d adoptive therapy of refractory infections","volume":"51","author":"O\u2019Reilly","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"2020121716301540700_B26","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"issue":"6","key":"2020121716301540700_B27","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.jproteome.9b00874","article-title":"Improved prediction of MHC II antigen presentation through integration and motif deconvolution of mass spectrometry MHC eluted ligand data","volume":"19","author":"Reynisson","year":"2020","journal-title":"J Proteome Res"},{"issue":"11","key":"2020121716301540700_B28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/s41587-019-0280-2","article-title":"Predicting HLA class II antigen presentation through integrated deep learning","volume":"37","author":"Chen","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2020121716301540700_B29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J Virol"},{"issue":"19","key":"2020121716301540700_B30","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"2020121716301540700_B31","doi-asserted-by":"crossref","first-page":"104389","DOI":"10.1016\/j.meegid.2020.104389","article-title":"Exploring the genomic and proteomic variations of SARS-CoV-2 spike glycoprotein: a computational biology approach","volume":"84","author":"Lokman","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"2","key":"2020121716301540700_B32","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.168.2.909","article-title":"Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals","volume":"168","author":"Savoldo","year":"2002","journal-title":"J Immunol"},{"issue":"6","key":"2020121716301540700_B33","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.4049\/jimmunol.0900722","article-title":"Detailed characterization of T cell responses to herpes simplex virus-2 in immune seronegative persons","volume":"184","author":"Posavad","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"2020121716301540700_B34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/JCMA.0000000000000335","article-title":"Genomic analysis and comparative multiple sequence of SARS-CoV2","volume":"83","author":"Chang","year":"2020","journal-title":"J Chin Med Assoc"},{"issue":"15","key":"2020121716301540700_B35","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/cid\/ciaa203","article-title":"Genomic diversity of SARS-CoV-2 in coronavirus disease 2019 patients","volume":"71","author":"Shen","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"14","key":"2020121716301540700_B36","doi-asserted-by":"crossref","first-page":"eaan5393","DOI":"10.1126\/sciimmunol.aan5393","article-title":"Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses","volume":"2","author":"Zhao","year":"2017","journal-title":"Sci Immunol"},{"key":"2020121716301540700_B37","article-title":"Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation [published online ahead of print 9 June 2020]","author":"Decker","journal-title":"Am J Transplant"},{"issue":"6","key":"2020121716301540700_B38","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.eururo.2020.03.039","article-title":"Coronavirus disease 2019 pneumonia in immunosuppressed renal transplant recipients: a summary of 10 confirmed cases in Wuhan, China","volume":"77","author":"Zhu","year":"2020","journal-title":"Eur Urol"},{"issue":"6508","key":"2020121716301540700_B39","doi-asserted-by":"crossref","first-page":"eabc8511","DOI":"10.1126\/science.abc8511","article-title":"Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications","volume":"369","author":"Mathew","year":"2020","journal-title":"Science"},{"issue":"12","key":"2020121716301540700_B40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jcyt.2016.08.010","article-title":"Human parainfluenza virus-3 can be targeted by rapidly ex vivo expanded T lymphocytes","volume":"18","author":"McLaughlin","year":"2016","journal-title":"Cytotherapy"},{"issue":"6","key":"2020121716301540700_B41","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/infdis\/jix358","article-title":"Immunologic profiling of human metapneumovirus for the development of targeted immunotherapy","volume":"216","author":"Tzannou","year":"2017","journal-title":"J Infect Dis"},{"issue":"8","key":"2020121716301540700_B42","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JVI.65.8.4494-4497.1991","article-title":"Respiratory syncytial virus infection in C57BL\/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells","volume":"65","author":"Mu\u00f1oz","year":"1991","journal-title":"J Virol"},{"issue":"21","key":"2020121716301540700_B43","doi-asserted-by":"crossref","first-page":"11654","DOI":"10.1128\/JVI.01510-12","article-title":"Long-term and memory immune responses in mice against Newcastle disease virus-like particles containing respiratory syncytial virus glycoprotein ectodomains","volume":"86","author":"Schmidt","year":"2012","journal-title":"J Virol"},{"issue":"4","key":"2020121716301540700_B44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-0039.2003.00103.x","article-title":"New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans","volume":"62","author":"Klitz","year":"2003","journal-title":"Tissue Antigens"},{"issue":"26","key":"2020121716301540700_B45","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"24","key":"2020121716301540700_B46","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/bloodadvances.2017010223","article-title":"Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells","volume":"1","author":"Withers","year":"2017","journal-title":"Blood Adv"},{"issue":"285","key":"2020121716301540700_B47","doi-asserted-by":"crossref","first-page":"285ra63","DOI":"10.1126\/scitranslmed.aaa2546","article-title":"CMV-specific T cells generated from na\u00efve T cells recognize atypical epitopes and may be protective in vivo","volume":"7","author":"Hanley","year":"2015","journal-title":"Sci Transl Med"},{"issue":"12","key":"2020121716301540700_B48","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","article-title":"Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT","volume":"125","author":"Feucht","year":"2015","journal-title":"Blood"},{"issue":"10237","key":"2020121716301540700_B49","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(20)31094-1","article-title":"Hyperinflammatory shock in children during COVID-19 pandemic","volume":"395","author":"Riphagen","year":"2020","journal-title":"Lancet"},{"issue":"7821","key":"2020121716301540700_B50","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"issue":"5","key":"2020121716301540700_B51","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"issue":"2","key":"2020121716301540700_B52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome [published correction appears in Blood. 2015;126(8):1048]","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2020121716301540700_B53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1182\/blood.2019000924","article-title":"Virus-specific T-cell therapies for patients with primary immune deficiency","volume":"135","author":"Keller","year":"2020","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/25\/2905\/1794560\/bloodbld2020008488.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/25\/2905\/1794560\/bloodbld2020008488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T19:44:07Z","timestamp":1669319047000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/25\/2905\/469713\/SARS-CoV-2-specific-T-cells-are-rapidly-expanded"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,17]]},"references-count":53,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2020,12,17]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020008488","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,17]]}}}